Skip to main content
. 2020 Mar 31;11:518. doi: 10.3389/fimmu.2020.00518

Figure 7.

Figure 7

BTLA+ DCs in active TB showed an increased expression of the co-stimulatory molecule CD86. The expression of the co-stimulatory molecule CD86 in DCs was determined by flow cytometry (n = 8). The gating strategy is shown in Figure S1. (A,B) show the positive rate (%) (A) and MFI (B) of CD86 expression between BTLA+ DCs and the counterpart BTLA DCs in HCs. (C,D) show the positive rate (%) (C) and MFI (D) of CD86 expression between BTLA+ DCs and BTLA DCs in APT. (E,F) show the mean frequency (%) (E) and MFI (H) of CD86 expression in BTLA+ tDCs/mDCs/pDCs between HCs and APT patients. (G,H) show the mean frequency (%) (G) and MFI (H) of CD86 expression in BTLA tDCs and mDCs between HCs and APT patients. The P-values are shown in each column (Student t-test). *P < 0.05, **P < 0.01, ***P < 0.001.